Cambridge website for Synthetic Biology resources

Compiled by Jim Haseloff at the University of Cambridge. SpannerPlantLogo140This site contains details of recent papers and activity in Synthetic Biology, with particular emphasis on: (i) development of standards in biology and DNA parts, (ii) microbial and (iii) plant systems, (iv) research and teaching in the field at the University of Cambridge, (v) hardware for scientific computing and instrumentation, (vi) tools for scientific productivity and collected miscellany.

Similar to the Cambridge-based Raspberry Pi and OpenLabTools initiatives, we promote the use of low cost and open source tools - in our case for use in biological engineering.

Google: Synthetic Biology news

Run mouse over list to see previews, click for full article.

Synthetic Biology in industry

Top Players Novamont, Arcadia, Elevance, Amyris Leading Dramatic Changes in Chemical Industry

As innovative startups in bio-based materials and chemicals reach the scale needed to make a commercial impact, Lux Research rates the field to pick the winners

BOSTON, Jan 17, 2012 (BUSINESS WIRE) -- A collection of innovative bio-based chemicals and materials start-ups --Novamont, Arcadia, Elevance, Amyris, Gevo and Solazyme, among them -- is rapidly maturing and attaining scale, promising to hasten the biggest change seen in the global chemicals industry in decades, according to a Lux Research report, titled "Assessing Innovator Evolution in Renewable Materials and Chemicals." To see which companies are best positioned to prosper in the current market environment, Lux Research applied its Lux Innovation Grid to rate 106 startups.

"Green materials have arrived, thanks to innovative start-ups," said Kalib Kersh, Lux Research Analyst and lead author of the report. "Small technology start-ups are bringing new technologies for creating new bio-based chemicals and materials, and their growth is forcing corporations in the field to take notice."

Lux analysts positioned companies active in bio-based materials and chemicals on the Lux Innovation Grid based on their Technical Value and Business Execution -- companies that are strong on both axes reach the "Dominant" quadrant -- and also assessed each company's maturity, and provided an overall Lux Take. Among their conclusions:

-- Synthetic biology is making a big impact. Leading Dominant companies using synbio include Amyris, Gevo, Solazyme, and Codexis, and some relative newcomers like BioAmber, Myriant, and Allylix also reach the Dominant quadrant. The number of high-scoring synthetic biology players points to a strong role for synthetic biology in renewable chemicals and materials for the foreseeable future.

-- Thermochemical players reaping a similar bounty without bugs. By creating compounds via more scalable catalytic and conventional chemical methods, thermochemical technologies avoid pitfalls of bioprocessing. The top five Dominant innovators in this space -- Virent, Ensyn, Avantium, Segetis and Elevance -- make the field another one of the strongest in the bio-based materials and chemicals space.

-- Algae remain challenging. Over several decades now, algae startups have failed to deliver, struggling to attain commercial viability. No company earned an overall "Positive" rating from Lux analysts. However, Solix BioSystems differentiates itself with key partnerships and waste utilization, just reaching the Dominant quadrant on the Lux Innovation Grid.

"Assessing Innovator Evolution in Renewable Materials and Chemicals," is part of the Lux Research Bio-based Materials and Chemicals Intelligence service.

About Lux Research

Lux Research provides strategic advice and on-going intelligence for emerging technologies. Leaders in business, finance and government rely on us to help them make informed strategic decisions. Through our unique research approach focused on primary research and our extensive global network, we deliver insight, connections and competitive advantage to our clients. Visit for more information.

SOURCE: Lux Research from

Research news at Cambridge University

Run mouse over list to see previews, click for full article.

European Association of Students & Postdocs in Synthetic Biology (EUSynBioS)

EUSynBioSprelimLogo240The European Association of Students & Postdocs in Synthetic Biology (EUSynBioS) invites you to join its pre-launch community. The EUSynBioS initiative seeks to shape and foster a network of young researchers active the nascent scientific discipline of synthetic biology within the European Union by means of providing an integrative central resource for interaction and professional development.

Key objectives of EUSynBioS include i) the implementation of a central web platform for sharing news and opportunities relevant to members of the community as well as for academic networking, ii) the arrangement and support of events for academic exchange and professional development, iii) liaison with representatives of industry, and iv) establishment of a primary contact for collaboration and exchange with related communities of synthetic biology students and postdocs abroad.

Registering as a member is free and can be completed within 30 seconds via the following link Students and postdocs who register as a EUSynBioS member will be able to:
o Access a large network of young researchers in synthetic biology for academic collaboration and exchange
o Share technical resources and teaching materials
o Stay informed about relevant events such as conferences, workshops, or social outings o Browse relevant jobs in academia and industry
o Use site visits and mentoring opportunities to interact with prospective employers
o Connect with members of related communities all over the world

By registering as a member prior to the official launch of EUSynBioS, you will not only make a statement of support which will have an impact on the resources available to the community in the future; you will also be given the chance to actively shape EUSynBioS right from the start, and have an edge when applying for a position on the Steering Committee. We are looking forward to your joining us ! Christian Boehm, University of Cambridge.